Co-Authors
This is a "connection" page, showing publications co-authored by Scott Solomon and Giuseppe Remuzzi.
Connection Strength
0.092
-
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial. Am J Nephrol. 2017; 46(6):488-497.
Score: 0.047
-
ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. Am J Kidney Dis. 2017 Oct; 70(4):522-531.
Score: 0.045